Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Matinas Biopharma Holdings, Inc. Common Stock
(NY:
MTNB
)
0.2340
+0.0010 (+0.43%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Matinas Biopharma Holdings, Inc. Common Stock
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
April 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
April 19, 2023
Via
Benzinga
Earnings Scheduled For March 15, 2023
↗
March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
March 14, 2023
Via
Benzinga
Earnings Outlook For Matinas BioPharma Hldgs
↗
March 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
March 09, 2023
Via
Benzinga
Matinas BioPharma: Q2 Earnings Insights
↗
August 11, 2022
Matinas BioPharma Hldgs (AMEX:MTNB) reported its Q2 earnings results on Thursday, August 11, 2022 at 06:15 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For August 11, 2022
↗
August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
Via
Benzinga
Matinas BioPharma Hldgs: Q1 Earnings Insights
↗
May 12, 2022
Matinas BioPharma Hldgs (AMEX:MTNB) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:15 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday
↗
October 24, 2022
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.
Via
Benzinga
The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
↗
May 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
A Preview Of Matinas BioPharma Hldgs's Earnings
↗
May 11, 2022
Matinas BioPharma Hldgs (AMEX:MTNB) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
HC Wainwright Reiterates Buy Rating On BioNTech, While Lowers Price Target
↗
April 12, 2022
HC Wainwright has reiterated its Buy rating on BioNTech SE (NASDAQ: BNTX) while reducing the price tar
Via
Benzinga
BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines
↗
April 11, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
Matinas BioPharma Inks mRNA-Based Vaccine Pact With BioNTech
↗
April 11, 2022
BioNTech SE (NASDAQ: BNTX) and Matinas BioPharma Holdings Inc (NYSE: MTNB) have
Via
Benzinga
Here's Why Matinas BioPharma Shares Are Rising
↗
April 11, 2022
Matinas BioPharma Holdings Inc (NASDAQ: MTNB) shares are trading higher by 10.4% at $0.86 after the company and BioNTech announced an exclusive research collaboration to...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
March 25, 2022
Good morning, trader! Get ready for one more busy day of investing today with the biggest pre-market stock movers for Friday!
Via
InvestorPlace
34 Stocks Moving in Friday's Pre-Market Session
↗
March 25, 2022
Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) rose 40.5% to $2.22 in pre-market trading after the company reported better-than-expected Q4 sales results and reaffirmed FY22...
Via
Benzinga
Matinas BioPharma Updates — Q4 2021 Earnings And Conference Call Recap
↗
March 21, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
↗
March 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative...
Via
Benzinga
Matinas BioPharma: Q4 Earnings Insights
↗
March 08, 2022
Matinas BioPharma Hldgs (AMEX:MTNB) reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:15 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Earnings Preview For Matinas BioPharma Hldgs
↗
March 07, 2022
Matinas BioPharma Hldgs (AMEX:MTNB) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement....
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
December 08, 2021
We've reached the halfway point of the week and there's no slowing down as we dive into the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
Earnings Scheduled For March 8, 2022
↗
March 08, 2022
Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •...
Via
Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
↗
March 06, 2022
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...
Via
Benzinga
22 Stocks Moving in Wednesday's Pre-Market Session
↗
December 08, 2021
Gainers Daré Bioscience, Inc. (NASDAQ: DARE) rose 45.2% to $3.08 in pre-market trading after the company reported the FDA approval of XACIATO Vaginal Gel as a treatment...
Via
Benzinga
51 Biggest Movers From Yesterday
↗
January 26, 2022
Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares climbed 46.2% to close at $22.68 on Tuesday after the company unveiled topline data for momelotinib in myelofibrosis patients...
Via
Benzinga
Is Next-Generation Drug Delivery Coming to a Hospital Near You?
↗
December 01, 2021
Photo by Anna Shvets on Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner...
Via
Benzinga
On Target: This Company Says It Delivers Drugs Exactly How You Need Them
↗
November 15, 2021
Photo by Anna Shvets from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
Earnings Scheduled For November 8, 2021
↗
November 08, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
